AwardTape · Defense awards · Medical · Diagnostics and lab supplies · FA282318P6011
FA282318P6011: -$6.6K purchase order to Alba Bioscience, Inc
Alba Bioscience, Inc holds a purchase order from Department of the Air Force with -$6.6K obligated since Oct 2023 and $66K obligated over its life, against a ceiling of $73K. Latest action Apr 9, 2024.
Red blood cell reagents
| PIID | FA282318P6011 |
|---|---|
| Type | purchase order |
| Company | Alba Bioscience, Inc |
| Agency | Department of the Air Force |
| Contracting office | FA2823 AFTC PZIO |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | -$6.6K |
| Total obligated (lifetime) | $66K |
| Ceiling (base and all options) | $73K |
| Base date | Dec 1, 2017 |
| Latest action | Apr 9, 2024 |
| End date | Nov 30, 2022 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | PA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial